Nuvio
Matthew Stannard is an experienced professional in the investment and life sciences sectors, currently serving as an Investor and Deal Flow Coordinator at Angel Investor Forum. Previously, Matthew held the position of Life Sciences Advisor at InterSystems and acted as an Investor and Board Observer at DeepLook Medical. Additionally, Matthew has invested in companies such as Nuvio and AtlasXomics Inc. Matthew holds a Master of Science (M.Sc) in Engineering and Applied Science with a focus on Biomedical Engineering from Yale University, complemented by education at the University of Medicine and Dentistry of New Jersey.
This person is not in the org chart
This person is not in any teams
Nuvio
46M Americans have a physical mobility difficulty. Founded by a Doctor of Physical Therapy and in partnership with world-class product engineering and design, we’re bringing a new approach to mobility devices so you can move better when you need it most. Nuvio's mission is to support optimal mobility for the patient/user, benefiting them and their family while also acting as thoughtful tools through which rehab professionals can leverage their skills and deliver high-quality care. We're doing this by developing smart and safe mobility solutions that are portable and simple to use.